Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cannabis Bioscience International Holdings (CBIH) Return on Sales (2022 - 2026)

Cannabis Bioscience International Holdings' Return on Sales history spans 5 years, with the latest figure at 0.09% for Q1 2026.

  • On a quarterly basis, Return on Sales rose 1.0% to 0.09% in Q1 2026 year-over-year; TTM through Feb 2026 was 0.04%, a 3.0% decrease, with the full-year FY2025 number at 0.02%, changed 0.0% from a year prior.
  • Return on Sales hit 0.09% in Q1 2026 for Cannabis Bioscience International Holdings, down from 0.02% in the prior quarter.
  • Over the last five years, Return on Sales for CBIH hit a ceiling of 0.0% in Q2 2024 and a floor of 0.1% in Q1 2025.
  • Historically, Return on Sales has averaged 0.04% across 5 years, with a median of 0.03% in 2025.
  • Biggest five-year swings in Return on Sales: increased 6bps in 2024 and later fell -7bps in 2025.
  • Tracing CBIH's Return on Sales over 5 years: stood at 0.03% in 2022, then skyrocketed by 44bps to 0.01% in 2023, then soared by 38bps to 0.01% in 2024, then plummeted by -102bps to 0.02% in 2025, then crashed by -399bps to 0.09% in 2026.
  • Business Quant data shows Return on Sales for CBIH at 0.09% in Q1 2026, 0.02% in Q4 2025, and 0.04% in Q3 2025.